Jiangsu Nanfang Medical Co., Ltd. Stock

Equities

603880

CNE100002WH0

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. 18:00:00 2024-04-25 EDT 5-day change 1st Jan Change
3.56 CNY +1.42% Intraday chart for Jiangsu Nanfang Medical Co., Ltd. +2.01% -30.06%

Financials

Sales 2022 545M 75.27M 103M Sales 2023 600M 82.82M 113M Capitalization 1.49B 205M 281M
Net income 2022 -14M -1.93M -2.64M Net income 2023 -147M -20.29M -27.73M EV / Sales 2022 3.92 x
Net Debt 2022 324M 44.78M 61.21M Net Debt 2023 351M 48.46M 66.25M EV / Sales 2023 3.07 x
P/E ratio 2022
-124 x
P/E ratio 2023
-9.98 x
Employees 858
Yield 2022 *
-
Yield 2023
-
Free-Float 37.53%
More Fundamentals * Assessed data
Dynamic Chart
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Ren Weiguo signed share transfer agreement to acquire 8% stake in Jiangsu Nanfang Medical Co., Ltd. from Li Ping for CNY 99.9 million. CI
Jiangsu Nanfang Medical Co., Ltd.(SHSE:603880) dropped from Shanghai Stock Exchange A Share Index CI
Jiangsu Nanfang Medical Co., Ltd.(SHSE:603880) dropped from Shanghai Stock Exchange Composite Index CI
Suzhou Fengruida Optoelectronics Technology Co., Ltd. signed a share transfer agreement to acquire 8% stake in Jiangsu Nanfang Medical Co., Ltd. from Li Ping for approximately CNY 140 million. CI
Jiangsu Nanfang Medical Co., Ltd. announced that it expects to receive CNY 299.200902 million in funding from Suzhou Fengruida Optoelectronics Technology Co., Ltd. CI
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Jiangsu Nanfang Medical Unit to Apply For 100 Million Yuan Bank Loan MT
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Inner Mongolia Huaxi Biotechnology Co., Ltd. announced that it expects to receive CNY 20 million in funding from Jiangsu Nanfang Medical Co., Ltd. CI
More news
1 day+1.42%
1 week+2.01%
Current month-15.24%
1 month-15.04%
3 months-27.64%
6 months-22.10%
Current year-30.06%
More quotes
1 week
3.43
Extreme 3.43
3.59
1 month
3.35
Extreme 3.35
4.35
Current year
3.21
Extreme 3.21
5.22
1 year
3.21
Extreme 3.21
5.53
3 years
3.21
Extreme 3.21
8.35
5 years
3.21
Extreme 3.21
18.83
10 years
3.21
Extreme 3.21
18.83
More quotes
Managers TitleAgeSince
Chief Executive Officer 63 12-10-25
Chairman 60 12-10-25
Director of Finance/CFO 59 96-02-29
Members of the board TitleAgeSince
Chief Executive Officer 63 12-10-25
Director/Board Member 59 03-03-31
Director of Finance/CFO 59 96-02-29
More insiders
Date Price Change Volume
24-04-26 3.56 +1.42% 1,642,617
24-04-25 3.51 +0.57% 1,136,240
24-04-24 3.49 0.00% 1,230,580
24-04-23 3.49 0.00% 1,532,594
24-04-22 3.49 0.00% 1,009,116

End-of-day quote Shanghai S.E., April 25, 2024

More quotes
Jiangsu Nanfang Medical Co., Ltd. is a China-based company which is mainly engaged in manufacture and sales of medical dressings and pharmaceutical products. The Company is mainly engaged in research and development, manufactures and sales of transdermal products, medical tape and bandages, sports protection products, first-aid kits, nursing products and others. The Company’s main products include Band-Aid, patches, medical tapes, plaster dressings, sports protection products, first-aid kits, care products and other products. The Company’s brands include MIAO-SHOU, Oushun and others.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. 603880 Stock